top of page
citrus bioflavonoids 2.png

Testing & Certification

01

Citrox® Effectiveness Against Selected Pathogens

01

Bacteria
 

  • Campylobacter jejuni

  • Escherichia coli

  • Klebsiella pneumoniae

  • Lactobacillus pentoaceticus

  • Legionella pneumophila (NCTC 11192)

  • Listeria monocytogenes

  • MRSA (clinical strain)

  • Mycobacterium fortuitum (NCTC 8573)

  • Proteus vulgaris

  • Pseudomonas aeruginosa (ATCC 15442)

02

Yeasts and Fungi

  • Aspergillus flavus

  • Aspergillus niger

  • Aspergillus terreus

  • Botrytis cinerea

  • Candida albicans

  • Candida glabrata

  • Chaetomium globosum

  • Cladosporium spp.

  • Colletotrichum spp.

  • Diplodia natalensis

  • Fusarium spp.

  • Geotrichum candidum

  • Mucor spp.

  • Penicillium spp.

  • Penicillium digitatum

  • Penicillium funiculosum

  • Penicillium italicum

  • Penicillium roqueforti

  • Phomopsis spp.

  • Pullularia pullulans

  • Pythium spp.

  • Trichophyton interdigitale

  • Trichophyton mentagrophytes

.

03

Viruses and Protozoa

  • Human rhinovirus

  • Influenza A

  • Human immunodeficiency virus (HIV)

  • SARS-CoV, Urbani strain

  • African swine fever virus

  • Avian influenza virus

  • Foot-and-mouth disease virus

  • Gumboro virus

  • Herpes simplex virus types 1 and 2

  • Varicella-zoster virus

  • Hepatitis A and B viruses

  • Newcastle disease virus

  • Severe acute respiratory syndrome (SARS)

  • SARS-CoV-2

  • Histomonas meleagridis

  • Giardia lamblia

  • Entamoeba histolytica

  • Blastocystis hominis

02

EN Standards

01

Citrox BCL

  • EN 1276 — Bactericidal: P. aeruginosa, S. aureus, E. hirae, E. coli

  • EN 13727 — Bactericidal: P. aeruginosa, S. aureus, E. hirae

  • EN 13624 — Yeasticidal: C. albicans

  • EN 1650 — Yeasticidal: C. albicans

  • EN 14476 — Virucidal: Vaccinia virus

  • Additional virucidal testing: SARS-CoV-2

02

Hard Surface Sealant

  • EN 13624 — Yeasticidal: C. albicans

  • EN 13727 — Bactericidal: P. aeruginosa, S. aureus, E. hirae

  • Additional virucidal testing: Vaccinia virus, SARS-CoV-2 and selected respiratory viruses

03

Surface Cleaner & Disinfectant Spray

  • EN 1650 — Yeasticidal: C. albicans

  • EN 1276 — Bactericidal: P. aeruginosa, S. aureus, E. hirae, E. coli

  • EN 13697 — Bactericidal: P. aeruginosa, S. aureus, E. hirae

04

Mist

  • EN 14476 — Virucidal: Vaccinia virus

  • EN 1276 — Bactericidal: P. aeruginosa, S. aureus, E. hirae, E. coli

  • EN 13624 — Yeasticidal: C. albicans

  • EN 1650 — Yeasticidal: C. albicans

  • EN 13727 — Bactericidal: P. aeruginosa, S. aureus, E. hirae

05

Alcohol-Free Hand Gel

  • EN 1500 — Hygienic hand-rub efficacy: E. coli

  • EN 14476 — Virucidal: Vaccinia virus

  • EN 13624 — Yeasticidal: C. albicans

  • EN 1650 — Yeasticidal: C. albicans

  • EN 13727 — Bactericidal: P. aeruginosa, S. aureus, E. hirae

03

Patents

01

Misting and Decontamination

Active.

02

Coating of Materials and Surfaces

Active.

03

Impregnation of Cellulose Materials

Active.

04

Food Preservation

Active.

05

Water Purification

Active.

04

Independent Studies

01

Solar Panel Array

Solar Panel Performance Study

Objective

Assess whether a Citrox®-based solar-panel treatment could improve energy output over a 12-month period.

​

Methodology

  • Independent 360-day rooftop study

  • Operational system comprising 4,011 solar panels

  • 63 panels treated with a Citrox®-based coating

  • Three assessed arrays: GAK 4, GAK 8 and GAK 14

  • Treated and untreated strings compared under identical conditions

  • Energy output recorded every 15 minutes

  • Same twice-yearly cleaning schedule applied to all panels

 

Results

  • Average energy gain: 5.15%

  • GAK 4: +5.62%

  • GAK 8: +5.22%

  • GAK 14: +4.62%

  • Immediate improvement following application

  • Higher output during peak sunlight

  • Earlier energy generation under low-light conditions

  • Performance gains maintained throughout the study

 

Estimated Financial Impact

  • €128.94 additional annual revenue per treated string

  • Up to €24,627 projected annually across the complete installation

 

Financial estimates relate specifically to the installation, energy values and assumptions used in the study.

​

Documentation

The complete independent study report is available upon request.

02

Making Bed

Bed-Bug Efficacy Study

Objective

Evaluate the insecticidal effectiveness of a Citrox®-based treatment against Cimex lectularius bed bugs.

​

Methodology

  • Controlled testing conducted in line with EPA guidelines

  • Treatment applied from a distance of 30 cm

  • Five treatment groups and five water-treated control groups

  • Immediate knock-down recorded after application

  • Mortality assessed after 24 and 96 hours

 

Results

  • Immediate knock-down: 100%

  • Mortality after 24 hours: 100%

  • Mortality after 96 hours: 100%

 

Results apply to the Citrox®-based treatment, application method and conditions assessed in the study.

​

Documentation

Detailed test methodology and results are available upon request.

05

Approvals & Conformity

01

DEFRA UK

Control of disease onset: Newcastle’s Disease, Foot and Mouth Diseas, Tuberculosis, Swine Fever.

02

HPA UK

Disinfection.

03

UK Leading Supermarkets

Fresh produce decontamination.

04

EU Organic Farming Regulations

Treatment of fresh produce.

06

Contact Us

Ready to Partner with Us?
Contact us today.

bottom of page